CClinicalTrials.gg
Active, not recruitingNCT03153449Updated Aug 28, 2026

ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population

An interventional study of ATTUNE Revision Knee System in Total Knee Arthroplasty in Primary Knee Arthroplasty, sponsored by DePuy Orthopaedics. Active, not recruiting at 34 sites in 10 countries. Open to participants aged 22 Years to 80 Years. Per ClinicalTrials.gov, last updated 2026-08-28.

Sponsored by DePuy Orthopaedics · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
400
Allocation
Not applicable
Ages
22 Years to 80 Years
Sex
All
01

Study summary

Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in complex primary total knee arthroplasty.

Read the detailed description

Within primary TKA, there are factors that lead to more complex procedures that include patients with high BMIs, advanced preoperative deformities and ligamentous laxity. Such cases may require the surgeon to treat using ancillary components, such as stems and/or augments and/or additional constraint.

This post-market study will evaluate the short/medium term clinical performance and medium term survivorship of the ATTUNE Revision system system, which includes instrumentation, in complex primary TKA. The study is designed as a worldwide non-comparative, multi-center study with each site initially having a cohort of approximately 20 Subjects to recruit. The study will enroll approximately 200 fixed bearing and approximately 200 rotating platform configurations.

The 2-year KOOS-ADL (activities of daily living) was selected as the primary endpoint because it will evaluate the post-operative period during which outcomes typically plateau and will therefore provide a good indication of longer term outcomes

Male and female Subjects, age 22-80 years, inclusive, who require a primary knee arthroplasty in a joint that, due to deformity, instability, bone loss etc., necessitates the use of implants found within the ATTUNE Revision knee system and are suitable candidates for TKA using the ATTUNE® Revision system are eligible for enrollment in this study.

02

Conditions studied

  • Primary Knee Arthroplasty

Keywords

  • complex primary, deformity, ligamentous laxity
03

Who can participate

Ages eligible
22 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Subject is male or female and between the ages of 22 and 80 years at the time of consent, inclusive.
  2. The decision to have knee replacement with the study device is regardless of the research.
  3. The devices are to be used according to the approved indications.
  4. Subject that is willing to give voluntary, written informed consent to participate in this clinical investigation and authorize the transfer of his/her information to the Sponsor
  5. Subject is currently not bedridden.
  6. Subject, in the opinion of the Investigator, is able to understand this clinical investigation and is willing and able to perform all study procedures and follow-up visits and co-operate with investigational procedures.
  7. Subject is able to read, and comprehend the Informed Consent Document as well as complete the required PROMs in either English or one of the available translations.
  8. Subject has not been diagnosed with an inflammatory arthritis (including gout, rheumatoid, psoriatic etc.)

Exclusion criteria

Exclusion Criteria:

  1. The Subject is a woman who is pregnant or lactating.
  2. Contralateral knee has already been enrolled in this study. If the Investigator plans to treat a potential study subject with either simultaneous (two (2) knees in one (1) surgical setting) or staged bilateral TKA, then this subject may be enrolled; however, only the first knee may be enrolled into this study.
  3. Subject had a contralateral amputation.
  4. Previous partial knee replacement (unicompartmental, bicompartmental or patellofemoral joint replacement) or primary TKA in affected knee.
  5. Subject is currently diagnosed with radicular pain from the spine that radiates into the limb to receive TKA.
  6. Subject has participated in a clinical investigation with an investigational product (drug or device) in the last three (3) months.
  7. Subject is currently involved in any personal injury litigation, medical-legal or worker's compensation claims.
  8. Subject, in the opinion of the Investigator, is a drug or alcohol abuser (in the last 5 years) or has a psychological disorder that could affect his/her ability to complete patient reported questionnaires or be compliant with follow-up requirements.
  9. Subject was diagnosed and is taking prescription medications to treat a muscular disorder that limits mobility due to severe stiffness and pain such as fibromyalgia or polymyalgia.
  10. Subject has a significant neurological or musculoskeletal disorder(s) or disease that may adversely affect gait or weight bearing activities (e.g., muscular dystrophy, multiple sclerosis, Charcot disease).
  11. Subject has a medical condition with less than five (5) years life expectancy as determined by the Investigator.
  12. Subject has been diagnosed with an inflammatory arthritis (including uncontrolled gout, rheumatoid, psoriatic etc.).

    -

04

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
400 participants (actual)

Study arms

  • Other
    ATTUNE Revision knee system

    The ATTUNE Revision knees system is complementary to the ATTUNE primary knee portfolio and includes both rotating platform (RP) and fixed bearing (FB) configurations. The system includes a full compliment of implants designed to address the challenges faced in complex primary knee surgeries. These implants include Stemmable tibial and femoral components, augments, sleeves and offsets

    Device: ATTUNE Revision Knee System in Total Knee Arthroplasty

Interventions

  • DeviceATTUNE Revision Knee System in Total Knee Arthroplasty

    Implants from the ATTUNE Revision Knee System will be used to treat subjects whose surgeons have determined their anatomy is such that the use of revision components are required to perform primary total knee arthroplasty

    Also known as: complex primary knee arthroplasty

05

What researchers measure

Primary outcomes

  1. KOOS ADL

    Evaluate change from preoperative baseline to the 2 yr timepoint in patient reported functional outcome, KOOS-ADL for the ATTUNE® Revision TKA FB and RP configurations.

    Time frame: 2 Years

Secondary outcomes

  1. Knee Injury and Osteoarthritis Outcome Score - Activities of Daily Living (KOOS-ADL)

    Evaluate change from preoperative baseline to the 5 yr timepoint in functional outcomes as measured using KOOS patient reported outcomes measure (PROM).

    Time frame: Baseline, 5 Year

  2. Patient's Knee Implant Performance (PKIP)

    Evaluate change from preoperative baseline to 5 yr timepoint in functional outcomes, satisfaction and quality of life assessments, as measured using the PKIP patient reported outcome measure

    Time frame: Baseline, 5 Year

  3. American Knee Society Score

    valuate change from preoperative baseline to 5 yr timepoint in functional outcomes assessments, patient satisfaction and expectations and clinical evaluations as measured using the AKS measure

    Time frame: Baseline, 5 Year

  4. EQ-5D-5L

    Evaluate change from preoperative baseline to 2 and 5 yr timepoints in functional outcomes and quality of life assessments, as measured using the EQ-5D-5L patient reported outcome measure

    Time frame: Baseline, 5 year

  5. VAS Pain Score

    Evaluate change from preoperative baseline to 5 yr timepoint in patient reported pain severity as measured using a modified VAS Pain Score (discrete numbers rather than a continual scale).

    Time frame: Baseline, 5 year

  6. American Knee Society Score

    Evaluate change from preoperative baseline to the 5 yr timepoint in patient reported satisfaction from the AKS 2011 over time as measured using a Likert scale.

    Time frame: Baseline, 5 year

  7. American Knee Society Score (surgeon evaluation)

    Estimate the change from preoperative baseline to the 5 yr timepoint in clinical outcomes using the 2011 AKS (surgeon evaluation)

    Time frame: Baseline, 5 year

  8. Adverse Events

    Evaluate type and frequency of Adverse Events

    Time frame: Intraoperative, 6 weeks, 1 yr., 2 yr., 3 yr., 4 yr., 5 yr.

  9. Readmissions

    Evaluate the timing, duration and reason for any readmissions stratified by adverse event type (operative site vs. systemic).

    Time frame: 6 weeks, 1 yr., 2 yr., 3 yr., 4 yr., 5 yr.

  10. Survivorship

    Evaluate survivorship of the ATTUNE® Revision TKA system for the PS FB and PS RP configurations and the combined PS FB and PS RP configurations using Kaplan-Meier survival analysis at 1, 2, 3, 4 and 5 years.

    Time frame: 1, 2, 3, 4 and 5 years

  11. Frequency of radiolucent line occurrence

    Evaluate ATTUNE® Revision TKA fixation through zonal radiographic analysis of the bone-implant interface at 1, 2 and 5 years after surgery compared to the first postoperative radiographs.

    Time frame: 1, 2 and 5 years

  12. Anatomic Tibiofemoral Alignment

    Evaluate any changes in anatomic tibiofemoral alignment at 1, 2 and 5 yrs compared to the first postoperative radiographs.

    Time frame: 1, 2 and 5 years

  13. Femoral component alignment

    Evaluate any changes in femoral component alignment at 1, 2 and 5 yrs compared to the first postoperative radiographs.

    Time frame: 1, 2 and 5 years

  14. Tibial component alignment

    Evaluate any changes in tibial component alignment at 1, 2 and 5 yrs compared to the first postoperative radiographs.

    Time frame: 1, 2 and 5 years

  15. Restoration of joint line

    Radiographically evaluate the restoration of joint line using the first postoperative radiographs according to the methodology of Figgie.

    Time frame: First post-operative radiograph (1 day)

06

Study locations

34 sites
  • Scripps Clinic Torrey Pines
    San Diego, California 92037, United States
  • Colorado Joint Replacement
    Denver, Colorado 80210, United States
  • Orthopaedic Center of the Rockies
    Fort Collins, Colorado 80525, United States
  • Orthopedic Partners
    Niantic, Connecticut 06357, United States
  • Florida Orthopedic Associates
    DeLand, Florida 32720, United States
  • Arthroplasty Foundation
    Louisville, Kentucky 40215, United States
  • University of Mississippi Medical Center
    Jackson, Mississippi 39216, United States
  • Dartmouth-Hitchcock Medical Center
    Lebanon, New Hampshire 03756, United States
  • Rothman Institute
    Egg Harbor, New Jersey 08234, United States
  • UNC Orthopaedics
    Chapel Hill, North Carolina 27514, United States
  • OrthoCarolina Hip and Knee Center
    Charlotte, North Carolina 28207, United States
  • The Ohio State University Wexner Medical Center
    Columbus, Ohio 43210, United States
  • Southern Joint Replacement Institute
    Nashville, Tennessee 37203, United States
  • Texas Institute for Hip & Knee Surgery
    Austin, Texas 78751, United States
  • Fondren Orthopedic Group
    Houston, Texas 77030, United States
  • Fremantle Hospital
    Fremantle, Australia
  • St. John of God Murdoch Hospital
    Perth, Australia
  • Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H.
    Linz, Austria
  • London Health Sciences Centre University Hospital
    London, Ontario, Canada
  • Concordia Joint Replacement
    Winnipeg, Canada
  • CHRU La Cavale Blanche
    Brest, France
  • Centre Hospitalier Universitaire de Rennes
    Rennes, France
  • Klinik und Poliklinik für Orthopädie und Sportorthopädie am Klinikum rechts der Isar der Technischen Universität Münche
    Munich, Germany
  • Asklepios Orthopädische Klinik Lindenlohe
    Schwandorf in Bayern, Germany
  • South Infirmary Public Hospital
    Cork, Ireland
  • University Hospital Maastricht
    Maastricht, Netherlands
  • Wellington Hospital
    Wellington, New Zealand
  • Hampshire Hospitals NHS Foundation Trust
    Basingstoke, United Kingdom
  • Victoria Hospital NHS Fife
    Kirkcaldy, United Kingdom
  • Chapel Allerton Orthopaedic Centre
    Leeds, United Kingdom
  • James Cook University Hospital
    Middlesbrough, United Kingdom
  • The Robert Jones and Agnes Hunt Orthopaedic Hospital NHS Foundation Trust
    Oswestry, United Kingdom
  • Nuffield Orthopaedic Centre
    Oxford, United Kingdom
  • Wrightington Hospital
    Wigan, United Kingdom
07

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

08

Registry details

Key details

Study ID
NCT03153449
Lead sponsor
DePuy Orthopaedics
Responsible party
Sponsor
First posted
May 15, 2017
Start date
Sep 19, 2017
Primary completion
Apr 17, 2028 (estimated)
Completion
Oct 17, 2030 (estimated)
Last update
Aug 28, 2026

Study contacts

Grant Jamgochian
study director · Sponsor GmbH

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion